Physicians Realty Trust Ready to Breakout?

NYSE: DOC | Physicians Realty Trust Common Shares of Beneficial Interest News, Ratings, and Charts

DOC – A resistance level has formed in the chart of Physicians Realty Trust (DOC). The stock could soon breakout. Learn when to enter a position to profit from this trade.

Physicians Realty Trust (DOC) is nearing a key resistance level.  If this level is surpassed, a breakout could occur.

DOC is a real estate investment trust in the U.S. healthcare sector. It acquires, develops, and leases healthcare properties to physicians, hospitals, and healthcare delivery systems.

Since healthcare is an essential service, and its tenants lease medical offices for long periods of time, DOC has been able to withstand the stay at home protocols of the pandemic. It currently owns $5 billion worth of medical office real estate and has an addressable market of $250 billion to $300 billion.

The company reported its latest financial results earlier this month. While earnings underperformed estimates, and was down 12.5% year over year, revenue outperformed and was up 2% year over year. Prior to this quarter, the company had a strong history of EPS growth and is expected to resume its growth next year.

DOC has long-term debt of $1.1 billion and cash of only $4 million as of the end of its latest quarter. Its current ratio is also only 0.7. While its net profit margin is 21.6%, its return on equity is quite low at 3.3%.

The stock is also considered overvalued with a P/E of 39.7 and a Price to Sales ratio of 8.9. It has shown relatively flat near and mid-term momentum. It has a “Buy” rating in our POWR Ratings system.

Take a look at the 1-year chart of DOC below with my added notations:

 Chart of DOC provided by TradingView

During the past several months, DOC has formed a key level of resistance at the $19 (red) mark. The stock has tested that level a couple of times after its spring rally and has now fallen back down from $19 again. A solid close above $19 should lead to higher prices for DOC.

A long trade could be entered on a breakthrough of the $19 resistance level.

Want to Discover More Great Trades?

I have explored virtually every flavor of technical analysis and chart pattern known to mankind. The sad fact is that the vast majority of them don’t work at all.

That is why I recently put together this special report to help investors focus on the only 5 chart patterns that matter…the ones that lead to the most timely and profitable stock trades. Click below to get your copy now!

5 WINNING Stock Chart Patterns

Have a good trading day!

Good luck!

Christian Tharp, CMT

@cmtstockcoach


DOC shares were trading at $17.81 per share on Wednesday morning, down $0.04 (-0.22%). Year-to-date, DOC has declined -0.65%, versus a 14.29% rise in the benchmark S&P 500 index during the same period.


About the Author: Christian Tharp, CMT


Christian is an expert stock market coach at the Adam Mesh Trading Group who has mentored more than 4,000 traders and investors. He is a professional technical analyst that is a certified Chartered Market Technician (CMT), which is a designation awarded by the CMT Association. Christian is also the author of the daily online newsletter Todays Big Stock. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
DOCGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

A Case of Stock Market Whiplash

Just when the stock market (SPY) was inches away from a record high at 4,000 it got saddled with 6 days of downward pressure. Why did this happen? Is the pain over? What happens next? Read on below for answers …

:  |  News, Ratings, and Charts

Mimecast Secures Stock of the Week Honors

Almost every single stock in the cyber security group is obscenely overpriced. That’s because it is riding one of the hottest growth trends around. However, if you dig deep enough you will find a growing firm in the group that is also a surprisingly good value. That is why MIME is our Stock of the Week.

:  |  News, Ratings, and Charts

Stay Away From These 3 Overvalued EV Stocks

The bullish EV industry outlook has helped many start-ups, without resources or products to trade at sky-high valuations. However, they do not have any substantial technological backing or production capacity to compete with the well-established players. Arcimoto (FUV), Electrameccanica Vehicles (SOLO), and XL Fleet (XL) are three such stocks that are currently trading at extremely high valuations and may witness a significant pullback in the near term.

:  |  News, Ratings, and Charts

4 Healthcare Stocks to Buy and Hold for the Long Term

The healthcare sector in the United States is on the cusp of major growth. Factors such as positivity around the COVID-19 vaccine, an ageing U.S. population, and optimism over developments in the treatment of fatal diseases in general are brightening the prospects for healthcare stocks. Novartis AG (NVS), Abbott Laboratories (ABT), Merck & Company, Inc (MRK), and Eli Lilly and Company (LLY) are cases in point. They are top players in the healthcare space that investors could buy now and hold for the long term.

:  |  News, Ratings, and Charts

Stay Away From These 3 Overvalued EV Stocks

The bullish EV industry outlook has helped many start-ups, without resources or products to trade at sky-high valuations. However, they do not have any substantial technological backing or production capacity to compete with the well-established players. Arcimoto (FUV), Electrameccanica Vehicles (SOLO), and XL Fleet (XL) are three such stocks that are currently trading at extremely high valuations and may witness a significant pullback in the near term.

Read More Stories

More Physicians Realty Trust Common Shares of Beneficial Interest (DOC) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All DOC News